Challenges in understanding psychiatric disorders and developing therapeutics: A role for zebrafish

DMM Disease Models and Mechanisms

Volumn 8, Issue 7, 2015, Pages 647-656

  McCammon, Jasmine M ^a   Sive, Hazel ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Animal models; Autism; Chemical screens; Co morbidities; Psychiatric disorders; Schizophrenia; Zebrafish

Indexed keywords

ARTICLE; CYTOPLASM; GENETIC CONSERVATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; INVERTEBRATE; MENTAL DISEASE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; ZEBRA FISH; ANIMAL; CAENORHABDITIS ELEGANS; CELL CULTURE TECHNIQUE; DISEASE MODEL; DROSOPHILA MELANOGASTER; EVOLUTION; GENETICS; MENTAL DISORDERS; MOUSE; PHENOTYPE; PHYSIOLOGY; TRANSGENIC ANIMAL; TRANSLATIONAL RESEARCH;

ANIMALIA; DANIO RERIO;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOLOGICAL EVOLUTION; CAENORHABDITIS ELEGANS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; MENTAL DISORDERS; MICE; PHENOTYPE; TRANSLATIONAL MEDICAL RESEARCH; ZEBRAFISH;

EID: 84937936413     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.019620     Document Type: Article

References (127)

1. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U. and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188.
2. Amsterdam, A. and Hopkins, N. (2006). Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet. 22, 473-478.
3. Asakawa, K. and Kawakami, K. (2008). Targeted gene expression by the Gal4-UAS system in zebrafish. Dev. Growth Differ. 50, 391-399.
4. Bai, X., Kim, J., Yang, Z., Jurynec, M. J., Akie, T. E., Lee, J., LeBlanc, J., Sessa, A., Jiang, H., DiBiase, A. et al. (2010). TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 142, 133-143.
5. Baraban, S. C., Taylor, M. R., Castro, P. A. and Baier, H. (2005). Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131, 759-768.
6. Ben Fredj, N., Hammond, S., Otsuna, H., Chien, C.-B., Burrone, J. and Meyer, M. P. (2010). Synaptic activity and activity-dependent competition regulates axon arbor maturation, growth arrest, and territory in the retinotectal projection. J. Neurosci. 30, 10939-10951.
7. Bittencourt, J., Velasques, B., Teixeira, S., Basile, L. F., Salles, J. I., Nardi, A. E., Budde, H., Cagy, M., Piedade, R. and Ribeiro, P. (2013). Saccadic eye movement applications for psychiatric disorders. Neuropsychiatr. Dis. Treatment 9, 1393-1409.
8. Blaker-Lee, A., Gupta, S., McCammon, J. M., De Rienzo, G. and Sive, H. (2012). Zebrafish homologs of genes within 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes. Dis. Model. Mech. 5, 834-851.
9. Brennan, C. H. (2011). Zebrafish behavioural assays of translational relevance for the study of psychiatric disease. Rev. Neurosci. 22, 37-48.
10. Brennand, K., Savas, J. N., Kim, Y., Tran, N., Simone, A., Hashimoto-Torii, K., Beaumont, K. G., Kim, H. J., Topol, A., Ladran, I. et al. (2014). Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 20, 361-368.
11. Bundey, S., Hardy, C., Vickers, S., Kilpatrick, M. W. and Corbett, J. A. (1994). Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev. Med. Child Neurol. 36, 736-742.
12. Buske, C. and Gerlai, R. (2012). Maturation of shoaling behavior is accompanied by changes in the dopaminergic and serotoninergic systems in zebrafish. Dev. Psychobiol. 54, 28-35.
13. Caglayan, A. O. (2010). Genetic causes of syndromic and non-syndromic autism. Dev. Med. Child Neurol. 52, 130-138.
14. Carten, J. D., Bradford, M. K. and Farber, S. A. (2011). Visualizing digestive organ morphology and function using differential fatty acid metabolism in live zebrafish. Dev. Biol. 360, 276-285.
15. Cocchiaro, J. L. and Rawls, J. F. (2013). Microgavage of zebrafish larvae. J. Vis. Exp., e4434.
16. Cross-Disorder Group of the Psychiatric Genomics Consortium and Genetic Risk Outcome of Psychosis Consortium. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379.
17. Culetto, E. and Sattelle, D. B. (2000). A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes. Hum. Mol. Genet. 9, 869-877.
18. Cutler, C., Multani, P., Robbins, D., Kim, H. T., Le, T., Hoggatt, J., Pelus, L. M., Desponts, C., Chen, Y.-B., Rezner, B. et al. (2013). Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 122, 3074-3081.
19. De Rienzo, G., Gutzman, J. H. and Sive, H. (2012). Efficient shRNA-mediated inhibition of gene expression in zebrafish. Zebrafish 9, 97-107.
20. Dodd, S., Maes, M., Anderson, G., Dean, O. M., Moylan, S. and Berk, M. (2013). Putative neuroprotective agents in neuropsychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 42, 135-145.
21. Dolen, G., Osterweil, E., Rao, B. S. S, Smith, G. B., Auerbach, B. D., Chattarji, S. and Bear, M. F. (2007). Correction of fragile X syndrome in mice. Neuron 56, 955-962.
22. Dueck, A., Thome, J. and Haessler, F. (2012). The role of sleep problems and circadian clock genes in childhood psychiatric disorders. J. Neural Transm. 119, 1097-1104.
23. Eckardt, S., McLaughlin, K. J. and Willenbring, H. (2011). Mouse chimeras as a system to investigate development, cell and tissue function, disease mechanisms and organ regeneration. Cell Cycle 10, 2091-2099.
24. Eisen, J. S. and Smith, J. C. (2008). Controlling morpholino experiments: don'tstop making antisense. Development 135, 1735-1743.
25. Fajardo, O., Zhu, P. and Friedrich, R. W. (2013). Control of a specific motor program by a small brain area in zebrafish. Front. Neural Circuits 7, 67.
26. Fatemi, S. H. and Folsom, T. D. (2011). The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology 60, 1221-1226.
27. Flinn, L., Bretaud, S., Lo, C., Ingham, P. W. and Bandmann, O. (2008). Zebrafish as a new animal model for movement disorders. J. Neurochem. 106, 1991-1997.
28. Fortney, K., Morgen, E. K., Kotlyar, M. and Jurisica, I. (2012). In silico drug screen in mouse liver identifies candidate calorie restriction mimetics. Rejuvenation Res. 15, 148-152.
29. Freyberg, Z., Ferrando, S. J. and Javitch, J. A. (2010). Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am. J. Psychiatry 167, 388-396.
30. Gauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A. et al. (2010). De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl. Acad. Sci. USA 107, 7863-7868.
31. Goessling, W., Allen, R. S., Guan, X., Jin, P., Uchida, N., Dovey, M., Harris, J. M., Metzger, M. E., Bonifacino, A. C., Stroncek, D. et al. (2011). Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 8, 445-458.
32. Golzio, C., Willer, J., Talkowski, M. E., Oh, E. C., Taniguchi, Y., Jacquemont, S., Reymond, A., Sun, M., Sawa, A., Gusella, J. F. et al. (2012). KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 485, 363-367.
33. Gottesman, I. I. and Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636-645.
34. Grant, S. G. N. (2012). Synaptopathies: diseases of the synaptome. Curr. Opin. Neurobiol. 22, 522-529.
35. Gratten, J., Wray, N. R., Keller, M. C. and Visscher, P. M. (2014). Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat. Neurosci. 17, 782-790.
36. Grayton, H. M., Fernandes, C., Rujescu, D. and Collier, D. A. (2012). Copy number variations in neurodevelopmental disorders. Prog. Neurobiol. 99, 81-91.
37. Grünblatt, E., Bartl, J., Marinova, Z. and Walitza, S. (2013). In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder. J. Neural Transm. 120, 131-139.
38. Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R. and Leboyer, M. (2013). Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications. Curr. Psychiatry Rep. 15, 387.
39. Han, X., Chen, M., Wang, F., Windrem, M., Wang, S., Shanz, S., Xu, Q., Oberheim, N. A., Bekar, L., Betstadt, S. et al. (2013). Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 12, 342-353.
40. Hao, J., Ao, A., Zhou, L., Murphy, C. K., Frist, A. Y., Keel, J. J., Thorne, C. A., Kim, K., Lee, E. and Hong, C. C. (2013). Selective small molecule targeting betacatenin function discovered by in vivo chemical genetic screen. Cell Rep. 4, 898-904.
41. Hashimoto, M. and Hibi, M. (2012). Development and evolution of cerebellar neural circuits. Dev. Growth Differ. 54, 373-389.
42. Hisano, Y., Ota, S. and Kawahara, A. (2013). Genome editing using artificial sitespecific nucleases in zebrafish. Dev. Growth Differ. 56, 26-33.
43. Howe, K. Clark, M. D. Torroja, C. F. Torrance, J. Berthelot, C. Muffato, M. Collins, J. E. Humphray, S. McLaren, K. Matthews, L. et al. (2013). The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498-503.
44. Hyman, S. E. (2012). Revolution stalled. Sci. Transl. Med. 4, 155cm111.
45. Hyman, S. E. (2014). Revitalizing psychiatric therapeutics. Neuropsychopharmacology 39, 220-229.
46. Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., Ramos, F. J., Cornish, K., He, Y., Paulding, C. et al. (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci. Transl. Med. 3, 64ra61.
47. Jao, L.-E., Wente, S. R. and Chen, W. (2013). Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. USA 110, 13904-13909.
48. Kanner, A. M. (2013). Do psychiatric comorbidities have a negative impact on the course and treatment of seizure disorders? Curr. Opin. Neurol. 26, 208-213.
49. Kawahara, G., Karpf, J. A., Myers, J. A., Alexander, M. S., Guyon, J. R. and Kunkel, L. M. (2011). Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 108, 5331-5336.
50. Kendler, K. S. (2013). What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol. Psychiatry 18, 1058-1066.
51. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R. and Walters, E. E. (2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 593-602.
52. Kessler, R. C., Chiu, W. T., Demler, O. and Walters, E. E. (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617-627.
53. Khwaja, O. S., Ho, E., Barnes, K. V., O'Leary, H. M., Pereira, L. M., Finkelstein, Y., Nelson, C. A., III, Vogel-Farley, V., DeGregorio, G., Holm, I. A. et al. (2014). Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc. Natl. Acad. Sci. USA 111, 4596-4601.
54. Kimura, Y., Satou, C., Fujioka, S., Shoji, W., Umeda, K., Ishizuka, T., Yawo, H. and Higashijima, S.-i. (2013). Hindbrain V2a neurons in the excitation of spinal locomotor circuits during zebrafish swimming. Curr. Biol. 23, 843-849.
55. Koboldt, D. C., Steinberg, K. M., Larson, D. E., Wilson, R. K. and Mardis, E. R. (2013). The next-generation sequencing revolution and its impact on genomics. Cell 155, 27-38.
56. Kohane, I. S., McMurry, A., Weber, G., MacFadden, D., Rappaport, L., Kunkel, L., Bickel, J., Wattanasin, N., Spence, S., Murphy, S. et al. (2012). The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS ONE 7, e33224.
57. Kok, F. O., Shin, M., Ni, C.-W., Gupta, A., Grosse, A. S., van Impel, A., Kirchmaier, B. C., Peterson-Maduro, J., Kourkoulis, G., Male, I. et al. (2015). Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell 32, 97-108.
58. Kokel, D., Bryan, J., Laggner, C., White, R., Cheung, C. Y. J., Mateus, R., Healey, D., Kim, S., Werdich, A. A., Haggarty, S. J. et al. (2010). Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 6, 231-237.
59. Lancaster, M. A. and Knoblich, J. A. (2014). Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125.
60. Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P. and Knoblich, J. A. (2013). Cerebral organoids model human brain development and microcephaly. Nature 501, 373-379.
61. Leblond, C. P. (1964). Classification of cell populations on the basis of their proliferative behavior. Natl. Cancer Inst. Monogr. 14, 119-150.
62. Li, Y., Xu, C. and Ma, T. (2014). In vitro organogenesis from pluripotent stem cells. Organogenesis 10, 159-163.
63. Lieschke, G. J. and Currie, P. D. (2007). Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-367.
64. Lord, C., Petkova, E., Hus, V., Gan, W., Lu, F., Martin, D. M., Ousley, O., Guy, L., Bernier, R., Gerdts, J. et al. (2012). A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch. Gen. Psychiatry 69, 306-313.
65. Maaswinkel, H., Zhu, L. and Weng, W. (2013). Assessing social engagement in heterogeneous groups of zebrafish: a new paradigm for autism-like behavioral responses. PLoS ONE 8, e75955.
66. Malhotra, D. and Sebat, J. (2012). CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148, 1223-1241.
67. Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H. and Muotri, A. R. (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527-539.
68. Martin, E. A., Barresi, R., Byrne, B. J., Tsimerinov, E. I., Scott, B. L., Walker, A. E., Gurudevan, S. V., Anene, F., Elashoff, R. M., Thomas, G. D. et al. (2012). Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy. Sci. Transl. Med. 4, 162ra155.
69. McBride, S. M. J., Choi, C. H., Wang, Y., Liebelt, D., Braunstein, E., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T. et al. (2005). Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45, 753-764.
70. McElhanon, B. O., McCracken, C., Karpen, S. and Sharp, W. G. (2014). Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 133, 872-883.
71. McEvoy, J. P., Lieberman, J. A., Stroup, T. S., Davis, S. M., Meltzer, H. Y., Rosenheck, R. A., Swartz, M. S., Perkins, D. O., Keefe, R. S. E., Davis, C. E. et al. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am. J. Psychiatry 163, 600-610.
72. McLaren, D., Gorba, T., Marguerie de Rotrou, A., Pillai, G., Chappell, C., Stacey, A., Lingard, S., Falk, A., Smith, A., Koch, P. et al. (2013). Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells. J. Biomol. Screen. 18, 258-268.
73. Meyer, M. P. and Smith, S. J. (2006). Evidence from in vivo imaging that synaptogenesis guides the growth and branching of axonal arbors by two distinct mechanisms. J. Neurosci. 26, 3604-3614.
74. Mouse Genome Sequencing Consortium, Waterston, R. H. Lindblad-Toh, K. Birney, E. Rogers, J. Abril, J. F. Agarwal, P. Agarwala, R. Ainscough, R. Alexandersson, M. et al. (2002). Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562.
75. Moy, S. S., Riddick, N. V., Nikolova, V. D., Teng, B. L., Agster, K. L., Nonneman, R. J., Young, N. B., Baker, L. K., Nadler, J. J. and Bodfish, J. W. (2014). Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism. Behav. Brain Res. 259, 200-214.
76. Muir-Cochrane, E. (2006). Medical co-morbidity risk factors and barriers to care for people with schizophrenia. J. Psychiatr. Mental Health Nurs. 13, 447-452.
77. Nasevicius, A. and Ekker, S. C. (2000). Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26, 216-220.
78. Neill, J. C., Barnes, S., Cook, S., Grayson, B., Idris, N. F., McLean, S. L., Snigdha, S., Rajagopal, L. and Harte, M. K. (2010). Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol. Ther. 128, 419-432.
79. Nestler, E. J. and Hyman, S. E. (2010). Animal models of neuropsychiatric disorders. Nat. Neurosci. 13, 1161-1169.
80. Ng, M.-C., Yang, Y.-L. and Lu, K.-T. (2013). Behavioral and synaptic circuit features in a zebrafish model of fragile X syndrome. PLoS ONE 8, e51456.
81. Norton, W. H. (2013). Toward developmental models of psychiatric disorders in zebrafish. Front. Neural Circuits 7, 79.
82. O'Leary, O. F. and Cryan, J. F. (2013). Towards translational rodent models of depression. Cell Tissue Res. 354, 141-153.
83. Panula, P., Chen, Y.-C., Priyadarshini, M., Kudo, H., Semenova, S., Sundvik, M. and Sallinen, V. (2010). The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol. Dis. 40, 46-57.
84. Pariante, C. M. (2009). Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann. N. Y. Acad. Sci. 1179, 144-152.
85. Randall, F. E., Garcia-Munoz, M., Vickers, C., Schock, S. C., Staines, W. A. and Arbuthnott, G. W. (2011). The corticostriatal system in dissociated cell culture. Front. Syst. Neurosci. 5, 52.
86. Ranga, A., Gjorevski, N. and Lutolf, M. P. (2014). Drug discovery through stem cell-based organoid models. Adv. Drug Deliv. Rev. 69-70C, 19-28.
87. Reeber, S. L., Otis, T. S. and Sillitoe, R. V. (2013). New roles for the cerebellum in health and disease. Front. Syst. Neurosci. 7, 83.
88. Reiter, L. T., Potocki, L., Chien, S., Gribskov, M. and Bier, E. (2001). A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 11, 1114-1125.
89. Renshaw, S. A. and Trede, N. S. (2012). A model 450 million years in the making: zebrafish and vertebrate immunity. Dis. Model. Mech. 5, 38-47.
90. Rihel, J., Prober, D. A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S. J., Kokel, D., Rubin, L. L., Peterson, R. T. et al. (2010). Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351.
91. Ripke, S. O'Dushlaine, C. Chambert, K. Moran, J. L. Kähler, A. K. Akterin, S. Bergen, S. E. Collins, A. L. Crowley, J. J. Fromer, M. et al. (2013). Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159.
92. Robertson, H. R. and Feng, G. (2011). Annual research review: transgenic mouse models of childhood-onset psychiatric disorders. J. Child Psychol. Psychiatry 52, 442-475.
93. Robu, M. E., Larson, J. D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S. A. and Ekker, S. C. (2007). p53 activation by knockdown technologies. PLoS Genet. 3, e78.
94. Rudrapatna, V. A., Cagan, R. L. and Das, T. K. (2012). Drosophila cancer models. Dev. Dyn. 241, 107-118.
95. Samocha, K. E., Robinson, E. B., Sanders, S. J., Stevens, C., Sabo, A., McGrath, L. M., Kosmicki, J. A., Rehnström, K., Mallick, S., Kirby, A. et al. (2014). A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 46, 944-950.
96. Sandanam, T., Beange, H., Robson, L., Woolnough, H., Buchholz, T. and Smith, A. (1997). Manifestations in institutionalised adults with Angelman syndrome due to deletion. Am. J. Med. Genet. 70, 415-420.
97. Saur, T., DeMarco, S. E., Ortiz, A., Sliwoski, G. R., Hao, L., Wang, X., Cohen, B. M. and Buttner, E. A. (2013). A genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug target. PLoS Genet. 9, e1003313.
98. Schoonheim, P. J., Arrenberg, A. B., Del Bene, F. and Baier, H. (2010). Optogenetic localization and genetic perturbation of saccade-generating neurons in zebrafish. J. Neurosci. 30, 7111-7120.
99. Schreiber, M., Dorschner, M. and Tsuang, D. (2013). Next-generation sequencing in schizophrenia and other neuropsychiatric disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B, 671-678.
100. Scott, E. K., Mason, L., Arrenberg, A. B., Ziv, L., Gosse, N. J., Xiao, T., Chi, N. C., Asakawa, K., Kawakami, K. and Baier, H. (2007). Targeting neural circuitry in zebrafish using GAL4 enhancer trapping. Nat. Methods 4, 323-326.
101. Shepherd, I. and Eisen, J. (2011). Development of the zebrafish enteric nervous system. Methods Cell Biol. 101, 143-160.
102. Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. and Livesey, F. J. (2012). Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 15, 477-486.
103. Shih, D.-F., Hsiao, C.-D., Min, M.-Y., Lai, W.-S., Yang, C.-W., Lee, W.-T. and Lee, S.-J. (2013). Aromatic L-amino acid decarboxylase (AADC) is crucial for brain development and motor functions. PLoS ONE 8, e71741.
104. Singh, K. K., De Rienzo, G., Drane, L., Mao, Y., Flood, Z., Madison, J., Ferreira, M., Bergen, S., King, C., Sklar, P. et al. (2011). Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development. Neuron 72, 545-558.
105. Sive, H. (2011). 'Model' or 'tool'? New definitions for translational research. Dis. Model. Mech. 4, 137-138.
106. Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K., Hoskins, E. E., Kalinichenko, V. V., Wells, S. I., Zorn, A. M. et al. (2011). Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105-109.
107. Stainier, D. Y. R., Kontarakis, Z. and Rossi, A. (2015). Making sense of anti-sense data. Dev. Cell 32, 7-8.
108. Stewart, A. M., Desmond, D., Kyzar, E., Gaikwad, S., Roth, A., Riehl, R., Collins, C., Monnig, L., Green, J. and Kalueff, A. V. (2012). Perspectives of zebrafish models of epilepsy: what, how and where next? Brain Res. Bull. 87, 135-143.
109. Stewart, A. M., Nguyen, M., Wong, K., Poudel, M. K. and Kalueff, A. V. (2013). Developing zebrafish models of autism spectrum disorder (ASD). Prog. Neuropsychopharmacol. Biol. Psychiatr. 50, 27-36.
110. Stuhlmiller, T. J. and García-Castro, M. I. (2012). Current perspectives of the signaling pathways directing neural crest induction. Cell. Mol. Life Sci. 69, 3715-3737.
111. Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N. et al. (2013). Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481-484.
112. Tayeh, M. K., Yen, H.-J., Beck, J. S., Searby, C. C., Westfall, T. A., Griesbach, H., Sheffield, V. C. and Slusarski, D. C. (2008). Genetic interaction between Bardet - Biedl syndrome genes and implications for limb patterning. Hum. Mol. Genet. 17, 1956-1967.
113. Toma, C., Hervá, A., Balmaña, N., Salgado, M., Maristany, M., Vilella, E., Aguilera, F., Orejuela, C., Cuscó, I., Gallastegui, F. et al. (2013). Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC. World J. Biol. Psychiatry 14, 516-527.
114. Trillenberg, P., Lencer, R. and Heide, W. (2004). Eye movements and psychiatric disease. Curr. Opin. Neurol. 17, 43-47.
115. Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R. and Sur, M. (2009). Partial reversal of Rett Syndromelike symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. USA 106, 2029-2034.
116. Voleti, B. and Duman, R. S. (2012). The roles of neurotrophic factor and Wnt signaling in depression. Clin. Pharmacol. Ther. 91, 333-338.
117. Wang, W., Qin, J.-J., Voruganti, S., Wang, M.-H., Sharma, H., Patil, S., Zhou, J., Wang, H., Mukhopadhyay, D., Buolamwini, J. K. et al. (2014). Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice. Gastroenterology 147, 893-902.e2.
118. Weger, B. D., Weger, M., Nusser, M., Brenner-Weiss, G. and Dickmeis, T. (2012). A chemical screening system for glucocorticoid stress hormone signaling in an intact vertebrate. ACS Chem. Biol. 7, 1178-1183.
119. Wei, H., Alberts, I. and Li, X. (2014). The apoptotic perspective of autism. Int. J. Dev. Neurosci. 36, 13-18.
120. Wheeler, G. N. and Brändli, A. W. (2009). Simple vertebrate models for chemical genetics and drug discovery screens: lessons from zebrafish and Xenopus. Dev. Dyn. 238, 1287-1308.
121. White, R. M., Cech, J., Ratanasirintrawoot, S., Lin, C. Y., Rahl, P. B., Burke, C. J., Langdon, E., Tomlinson, M. L., Mosher, J., Kaufman, C. et al. (2011). DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518-522.
122. White, R., Rose, K. and Zon, L. (2013). Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer 13, 624-636.
123. Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N. et al. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382, 1575-1586.
124. Wullimann, M. F. (2009). Secondary neurogenesis and telencephalic organization in zebrafish and mice: a brief review. Integr. Zool. 4, 123-133.
125. Wyart, C., Del Bene, F., Warp, E., Scott, E. K., Trauner, D., Baier, H. and Isacoff, E. Y. (2009). Optogenetic dissection of a behavioural module in the vertebrate spinal cord. Nature 461, 407-410.
126. Yan, Q. J., Rammal, M., Tranfaglia, M. and Bauchwitz, R. P. (2005). Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053-1066.
127. Ziv, L., Muto, A., Schoonheim, P. J., Meijsing, S. H., Strasser, D., Ingraham, H. A., Schaaf, M. J. M., Yamamoto, K. R. and Baier, H. (2013). An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol. Psychiatry 18, 681-691.